Inverse relationship of serum hepcidin levels with CD4 cell counts in HIV-infected patients selected from an Indonesian prospective cohort study

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Wisaksana, Rudi ^a   De Mast, Quirijn ^b   Alisjahbana, Bachti ^a   Jusuf, Hadi ^a   Sudjana, Primal ^a   Indrati, Agnes R ^a   Sumantri, Rachmat ^a   Swinkels, Dorine ^b   Van Crevel, Reinout ^b   Van Der Ven, Andre ^b  

^a PADJADJARAN UNIVERSITY   (Indonesia)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; HEPCIDIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HORMONE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERFERRITINEMIA; INDONESIA; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; FERRITINS; HEMOGLOBINS; HEPATITIS C; HEPCIDINS; HIV INFECTIONS; HUMANS; INDONESIA; IRON; MALE; PROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 84893165548     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079904     Document Type: Article

References (40)

1. Ganz T (2011) Hepcidin and iron regulation, 10 years later. Blood 117: 4425-4433.
2. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093. (Pubitemid 40007660)
3. de Monye C, Karcher DS, Boelaert JR, Gordeuk VR (1999) Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS 13: 375-380. (Pubitemid 29095100)
4. McDermid JM, Jaye A, Schim van der Loeff MF, Todd J, Bates C, et al. (2007) Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr 46: 498-507.
5. Drakesmith H, Prentice A (2008) Viral infection and iron metabolism. Nat Rev Microbiol 6: 541-552. (Pubitemid 351863367)
6. Nekhai S, Kumari N, Dhawan S (2013) Role of cellular iron and oxygen in the regulation of HIV-1 infection. Future Virol 8: 301-311
7. Xu M, Kashanchi F, Foster A, Rotimi J, Turner W, et al. (2010) Hepcidin induces HIV-1 transcription inhibited by ferroportin. Retrovirology 7: 104.
8. Belperio PS, Rhew DC (2004) Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 116 Suppl 7A: 27S-43S.
9. Lundgren JD, Mocroft A (2003) Anemia and survival in human immunodeficiency virus. Clin Infect Dis 37 Suppl 4: S297-S303. (Pubitemid 37431006)
10. Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, et al. (2004) Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis 38: 1454-1463. (Pubitemid 38668593)
11. Wisaksana R, Sumantri R, Indrati AR, Zwitser A, Jusuf H, et al. (2011) Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia. BMC Infect Dis 11: 213.
12. Boelaert JR, Vandecasteele SJ, Appelberg R, Gordeuk VR (2007) The effect of the host' iron status on tuberculosis. J Infect Dis 195: 1745-1753. (Pubitemid 46870246)
13. Baker MA, Wilson D, Wallengren K, Sandgren A, Iartchouk O, et al. (2012) Polymorphisms in the Gene that encodes the iron transport protein ferroportin 1 influence susceptibility to tuberculosis. J Infect Dis 205: 1043-1047.
14. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, et al. (2007) Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukoc Biol 82: 934-945. (Pubitemid 47511054)
15. Masaisa F, Breman C, Gahutu JB, Mukiibi J, Delanghe J, et al. (2012) Ferroportin (SLC40AI) Q248H mutation is associated with lower circulating serum hepcidin levels in Rwandese HIV-positive women. Ann Hematol 91: 911-916.
16. Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, et al. (2007) Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med13: 97-104. (Pubitemid 46786838)
17. Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, et al. (2009) Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol 51: 845-852.
18. Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, et al. (2011) Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 117: e218-e225.
19. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, et al. (2006) The WHO public-health approach to antiretroviral treatment against HIV in resourcelimited settings. Lancet 368: 505-510. (Pubitemid 44142772)
20. Parwati I, van Crevel R, van Soolingen D, van der Zanden A (2003) Application of spoligotyping to noncultured Mycobacterium tuberculosis bacteria requires an optimized approach. J Clin Microbiol 41: 5350-5351. (Pubitemid 37429980)
21. Stop TB Department of HIV/AIDS WHO (2006) Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resourceconstrained settings. Geneva: World Health Organization.
22. Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, et al. (2010) Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 56: 1570-1579.
23. Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, et al. (2008) Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One 3: e2706.
24. www.hepcidinanalysis.com, accessed June 2012.
25. de Mast Q, Nadjm B, Reyburn H, Kemna EH, Amos B, et al. (2009) Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis 199: 253-262.
26. O'rien ME, Kupka R, Msamanga GI, Saathoff E, Hunter DJ, et al. (2005) Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr 40: 219-225.
27. Kanda J, Mizumoto C, Kawabata H, Tsuchida H, Tomosugi N, et al. (2008) Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica 93: 1550-1554.
28. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S (2006) Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108: 3730-3735. (Pubitemid 44864551)
29. Sow FB, Nandakumar S, Velu V, Kellar KL, Schlesinger LS, et al. (2011) Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis (Edinb) 91: 314-321.
30. Roy CN, Mak HH, Akpan I, Losyev G, Zurakowski D, et al. (2007) Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109: 4038-4044. (Pubitemid 46641759)
31. Dallalio G, Law E, Means RT Jr (2006) Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 107: 2702-2704.
32. Drakesmith H, Chen N, Ledermann H, Screaton G, Townsend A, et al. (2005) HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc Natl Acad Sci U S A 102: 11017-11022. (Pubitemid 41105985)
33. Camaschella C, Poggiali E (2009) Towards explaining "nexplained hyperferritinemia" Haematologica 94: 307-309.
34. Hearnshaw S, Thompson NP, McGill A (2006) The epidemiology of hyperferritinaemia. World J Gastroenterol 12: 5866-5869. (Pubitemid 44594256)
35. Tripathi PB, Amarapurkar AD (2009) Morphological spectrum of gastrointestinal tuberculosis. Trop Gastroenterol 30: 35-39.
36. Visser A, van de Vyver (2011) Severe hyperferritinemia in Mycobacteria tuberculosis infection. Clin Infect Dis 52: 273-274.
37. Silva IS, Perez RM, Oliveira PV, Cantagalo MI, Dantas E, et al. (2005) Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study. J Gastroenterol Hepatol 20: 243-248. (Pubitemid 40343276)
38. Chartier L, Leng C, Sire JM, Le Minor O, Saman M, et al. (2011) Factors associated with negative direct sputum examination in Asian and African HIVinfected patients with tuberculosis (ANRS 1260). PLoS One 6: e21212.
39. Lawn SD, Wood R (2011) Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 204 Suppl 4: S1159-S1167.
40. Cohen K, Meintjes G (2010) Management of individuals requiring antiretroviral therapy and TB treatment. Curr Opin HIV AIDS 5:61-9.